Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden

Heit, 2000, Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study, Arch Intern Med, 160, 809, 10.1001/archinte.160.6.809 Noldus, 1994, Early complications of radical prostatectomy. Pelvic vein compression caused by wound drainage, Urologe A, 33, 172 Heidrich, 2009, Asymptomatic venous thrombosis in cancer patients–a problem often overlooked. Results of a retrospective and prospective study, Vasa, 38, 160, 10.1024/0301-1526.38.2.160 Klevecka, 2007, Intraoperative and early postoperative complications of radical retropubic prostatectomy, Urol Int, 79, 217, 10.1159/000107953 Scarpa, 2007, Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study, Eur Urol, 51, 130, 10.1016/j.eururo.2006.07.014 White, 2009, Effects of race and ethnicity on the incidence of venous thromboembolism, Thromb Res, 123, S11, 10.1016/S0049-3848(09)70136-7 Seaman, 2007, Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database, BJU Int, 99, 1398, 10.1111/j.1464-410X.2007.06859.x Varenhorst, 1981, Effects of estrogen, orchidectomy, and cyproterone acetate on tissue fibrinolysis in patients with carcinoma of the prostate, Invest Urol, 18, 355 Varenhorst, 1981, The effects of orchiectomy, oestrogens and cyproterone-acetate on the antithrombin-III concentration in carcinoma of the prostate, Urol Res, 9, 25, 10.1007/BF00256835 Saigal, 2007, Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer, Cancer, 110, 1493, 10.1002/cncr.22933 Jones, 2005, Testosterone and atherosclerosis in aging men: purported association and clinical implications, Am J Cardiovasc Drugs, 5, 141, 10.2165/00129784-200505030-00001 Sajjad, 2007, Androgen receptors are expressed in a variety of human fetal extragenital tissues: an immunohistochemical study, Asian J Androl, 9, 751, 10.1111/j.1745-7262.2007.00320.x Schock, 2006, Expression of androgen-binding protein (ABP) in human cardiac myocytes, Horm Metab Res, 38, 225, 10.1055/s-2006-925331 Klapcinska, 2008, Effects of castration and testosterone replacement on the antioxidant defense system in rat left ventricle, J Physiol Sci, 58, 173, 10.2170/physiolsci.RP002208 Golden, 2005, Acute actions of testosterone on contractile function of isolated rat ventricular myocytes, Eur J Endocrinol, 152, 479, 10.1530/eje.1.01845 Li, 2007, Experimental arterial thrombosis regulated by androgen and its receptor via modulation of platelet activation, Thromb Res, 121, 127, 10.1016/j.thromres.2007.03.008 Huggins, 1972, Studies on prostatic cancer I: The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate, CA Cancer J Clin, 22, 232, 10.3322/canjclin.22.4.232 Damber, 2008, Prostate cancer, Lancet, 371, 1710, 10.1016/S0140-6736(08)60729-1 Shahinian, 2005, Increasing use of gonadotropin-releasing hormone agonists for the treatment of localized prostate carcinoma, Cancer, 103, 1615, 10.1002/cncr.20955 Stattin, 2008, Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden, J Urol, 180, 2423, 10.1016/j.juro.2008.08.044 Barlow, 2009, The completeness of the Swedish Cancer Register: a sample survey for year 1998, Acta Oncol, 48, 27, 10.1080/02841860802247664 Adolfsson, 2007, Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005, Scand J Urol Nephrol, 41, 456, 10.1080/00365590701673625 Hammar, 2001, A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden, Int J Epidemiol, 30, S30, 10.1093/ije/30.suppl_1.S30 Ingelsson, 2005, The validity of a diagnosis of heart failure in a hospital discharge register, Eur J Heart Fail, 7, 787, 10.1016/j.ejheart.2004.12.007 Lindblad, 1993, Validity of register data on acute myocardial infarction and acute stroke: the Skaraborg Hypertension Project, Scand J Soc Med, 21, 3, 10.1177/140349489302100102 Hagel, 2009, PCBaSe Sweden: a register-based resource for prostate cancer research, Scand J Urol Nephrol, 43, 342, 10.3109/00365590903024577 Oefelein, 1998, Idiopathic thromboembolism as the presenting sign of occult prostate cancer, Urology, 51, 775, 10.1016/S0090-4295(98)00008-9 Breslow, 1987, Statistical methods in cancer research. Volume II–The design and analysis of cohort studies, IARC Sci Publ, 82, 406 Zar, 2008, Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestine, Eur J Cancer, 44, 718, 10.1016/j.ejca.2007.12.003 Jones, 1998, Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths, Am J Epidemiol, 148, 1012, 10.1093/oxfordjournals.aje.a009567 Engholm Stattin P, Holmberg E, Johansson J, Holmberg L, Adolfsson J, Hugosson J. Outcomes for men with localized prostate cancer in the National Prostate Cancer Register (NPCR) of Sweden. J Natl Cancer Inst (in press). Secin, 2008, Multi-institutional study of symptomatic deep venous thrombosis and pulmonary embolism in prostate cancer patients undergoing laparoscopic or robot-assisted laparoscopic radical prostatectomy, Eur Urol, 53, 134, 10.1016/j.eururo.2007.05.028 Lee, 2003, Venous thromboembolism and cancer: risks and outcomes, Circulation, 107, I17, 10.1161/01.CIR.0000078466.72504.AC Babiker, 2007, Prothrombotic effects of prostasomes isolated from prostatic cancer cell lines and seminal plasma, Semin Thromb Hemost, 33, 80, 10.1055/s-2006-958466 Toorians, 2003, Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people, J Clin Endocrinol Metab, 88, 5723, 10.1210/jc.2003-030520 Winkler, 1996, Effects of androgens on haemostasis, Maturitas, 24, 147, 10.1016/S0378-5122(96)82004-4 Heidenreich, 2008, Androgen deprivation for advanced prostate cancer, Urologe A, 47, 270, 10.1007/s00120-008-1636-2 Miettinen, 1983, The need for randomization in the study of intended effects, Stat Med, 2, 267, 10.1002/sim.4780020222 Giovannucci, 1999, Smoking and risk of total and fatal prostate cancer in United States health professionals, Cancer Epidemiol Biomarkers Prev, 8, 277